Court Dismisses Injunction to Block EGM of Enzychem Lifesciences, Removing Governance Risk
Enzychem Lifesciences disclosed that the Cheongju District Court Jecheon Branch dismissed the provisional injunction application to prohibit holding an extraordinary general meeting on July 22, 2026.
The applicant Nam○○ filed primary and preliminary claims, but the court found them groundless, dismissing all and ordering the applicant to bear the costs.
This ruling removes the legal obstacle to the EGM, resolving uncertainty related to the management dispute.
The litigation is a legal proceeding with no direct financial impact on stock value or capital structure.
[AI Summary]The court's dismissal of the injunction reduces management dispute risk. This could positively affect short-term stock price, but further litigation potential remains under monitoring.
KOSDAQ Filing Information
Judgment/Decision on Lawsuit, etc. (Provisional Injunction to Prohibit Holding Extraordinary General Meeting of Shareholders)